The long non‐coding RNA KDM4A ‐ AS1 protects β‐cell function via the miR ‐423‐5p/growth differentiation factor 11 axis
Diabetic Medicine · 2026-07 · 43 (7)
DOI: 10.1111/dme.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 03.04.2026. Verfasst von Yan Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Department, Ganzhou Women and Children's Health Care Hospital, Ganzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is the most common type of diabetes, which can cause various complications that threaten health. Long non‐coding RNA (lncRNA) is associated with the occurrence and development of diabetes and its complications.
Aim
The aim is to explore the regulatory mechanism of lncRNA KDM4A‐AS1 on T2DM and on the function of pancreatic β cells.
Methods
We enrolled 98 T2DM patients and 91 healthy controls, measuring serum and cellular factor expression via RT‐qPCR. Proliferation was assessed with CCK‐8, apoptosis by flow cytometry and insulin secretion by ELISA. We confirmed KDM4A‐AS1/miR‐423‐5p and miR‐423‐5p/ growth differentiation factor 11(GDF11) interactions using RNA immunoprecipitation and dual‐luciferase reporter assays.
Results
In the serum of patients with T2DM, the expressions of KDM4A‐AS1 and GDF11 were significantly downregulated, while the expression of miR‐423‐5p was significantly upregulated. The level of KDM4A‐AS1 was negatively correlated with fasting plasma glucose (FPG) and glycosylated haemoglobin (HbAlc). KDM4A‐AS1 has a good diagnostic value for T2DM. Experiments conducted in vitro demonstrated that overexpression of KDM4A‐AS1 could promote the expression of insulin synthesis genes Ins1 and Ins2, increase the amount of insulin secretion stimulated by glucose and simultaneously increase the cell proliferation rate and reduce the apoptosis rate. Mechanism studies have confirmed that KDM4A‐AS1 can directly target miR‐423‐5p and exert protective effects on pancreatic β cells by regulating the expression of downstream GDF11.
Conclusions
This study reveals that KDM4A‐AS1 protects β‐cell function through the miR‐423‐5p/GDF11 axis, providing a new potential target for the diagnosis and treatment of T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Department, Ganzhou Women and Children's Health Care Hospital, Ganzhou, China.
- Central Medical District of Chinese PLA General Hospital, Beijing, China.
- Endocrinology and Metabolic Diseases Department, Yantai Yantaishan Hospital, Yantai, China.
- Health Examination Center and External Relations Office, The Central Hospital of Haining, Haining, China.
- Department of Emergency, Hebei Provincial Traditional Chinese Medicine Hospital, Shijiazhuang, China.
ORCID-Profile: Zhongyun Huang
Zitieren
APA
Zeng, Y., Sun, L., Li, J., Huang, Z., & Yin, P. (2026). The long non‐coding RNA KDM4A ‐ AS1 protects β‐cell function via the miR ‐423‐5p/growth differentiation factor 11 axis. Diabetic Medicine, 43(7). https://doi.org/10.1111/dme.70309
Vancouver
Zeng Y, Sun L, Li J, Huang Z, Yin P. The long non‐coding RNA KDM4A ‐ AS1 protects β‐cell function via the miR ‐423‐5p/growth differentiation factor 11 axis. Diabetic Medicine. 2026;43(7). doi:10.1111/dme.70309
BibTeX
@article{Zeng2026,
author = {Zeng, Yan and Sun, Liyu and Li, Junli and Huang, Zhongyun and Yin, Pengying},
title = {The long non‐coding RNA KDM4A ‐ AS1 protects β‐cell function via the miR ‐423‐5p/growth differentiation factor 11 axis},
journal = {Diabetic Medicine},
year = {2026},
volume = {43},
number = {7},
doi = {10.1111/dme.70309}
}
EUVIMED